Log in to your Inderes Free account to see all free content on this page.

Enzymatica

2.54 SEK

+2.01%

Less than 1K followers

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Enzymatica

EV/S

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)3.6717.298.084.163.651.581.90
Shares154.5154.5157.6177.6177.6242.7242.7
Market cap567.02,670.81,273.6739.2648.0383.5461.2
Enterprise value540.22,659.51,244.6----
EV/S8.823.921.7----
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B4.7625.0410.195.858.462.173.71
P/S9.224.022.215.112.78.48.6
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio80.7 %65.8 %79.6 %72.4 %60.8 %90.3 %87.5 %
Gearing ratio2.1 %12.0 %1.2 %17.7 %34.1 %1.2 %0.8 %
Login required

This content is only available for logged in users